Seminars in nuclear medicine Journal

Overview

publication venue for

Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.. 37. 2007
Overview of Prospective Investigation of Pulmonary Embolism Diagnosis II.. 32. 2002
Infection imaging with technetium-99m-labeled chemotactic peptide analogs.. 24. 1994
Pharmacologic intervention in cardiovascular nuclear medicine procedures.. 11. 1981
Physiologic Intervention in Cardiovascular Nuclear Medicine.. 11. 1981
Radioimmunoassay: review of basic principles.. 5. 1975
Guest Editorial.. 46. 2016
Hypoxia imaging. Guest editorial.. 45. 2015
Guest Editorial: new PET radiopharmaceuticals as molecular imaging probes.. 41. 2011
Current status of radiolabeled peptides in nuclear medicine diagnosis and therapy.. 32. 2002
Cardiac Imaging With ¹²³I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives. 2020
Targeted Radionuclide Therapy: A Historical and Personal Review. 2019
Contribution of Radiology to Staging of Prostate Cancer. 2019
Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging. 2018
I-131 Metaiodobenzylguanidine Therapy of Pheochromocytoma and Paraganglioma. 2016
Novel Approaches to Thyroid Cancer Treatment and Response Assessment. 2016
A Perspective of the Future of Nuclear Medicine Training and Certification. 2016
The Potential of Metabolic Imaging. 2016
Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone). 2015
Accuracy and precision of radioactivity quantification in nuclear medicine images. 2012
Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology. 2011
A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? 2011
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. 2011
The next generation of positron emission tomography radiopharmaceuticals in oncology. 2011
Lymph node dissection in papillary thyroid carcinoma. 2011
Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States. 2011
Thyroid cancer--indications and opportunities for positron emission tomography/computed tomography imaging. 2011
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. 2011
Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. 2010
Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. 2009
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. 2009
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). 2008
Perfusion lung scintigraphy for the diagnosis of pulmonary embolism: a reappraisal and review of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis methods. 2008
Small-scale dosimetry: challenges and future directions. 2008
Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. 2008
Respiratory motion in positron emission tomography/computed tomography: a review. 2008
Fundamentals of molecular imaging: rationale and applications with relevance for radiation oncology. 2008
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. 2007
Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. 2007
Positron emission tomography for prostate, bladder, and renal cancer. 2004
Positron emission imaging of head and neck cancer, including thyroid carcinoma. 2004
Molecular imaging in nuclear cardiology. 2004
The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. 2001
The Chernobyl accident and its consequences: update at the millennium. 2000
Receptor imaging: competitive or complementary to antibody imaging? 1997
Somatostatin-receptor imaging in lymphoma. 1995
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases. 1992
Advances in ultrasound imaging of venous thrombosis. 1991
Single photon tomography in Alzheimer's disease and the dementias. 1990
99mTc-low density lipoprotein: intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo. 1990
Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanoma. 1989
Radionuclide cineangiography in acute myocardial infarction: role in prognostication. 1987
Nuclear oncology 1984. 1984
Clinical nuclear magnetic resonance imaging of the body. 1983
Current status of ventilation-perfusion imaging. 1980
Mechanisms of localization of gallium-67 in tumors. 1978

Identity

ISO Abbreviation

Semin Nucl Med

Linking ISSN

0001-2998

International Standard Serial Number (ISSN)

0001-2998

Electronic International Standard Serial Number (EISSN)

1558-4623